Bone Marrow Adipocyte: An Intimate Partner With Tumor Cells in Bone Metastasis

Area of Science:

• Oncology
• Cell Biology
• Cancer Metastasis Research

Background:

• Bone metastasis is a significant clinical challenge in breast, prostate, and lung cancers.
• The bone marrow microenvironment, or 'soil', plays a critical role in tumor cell colonization, yet is understudied compared to tumor cells ('seeds').
• Bone marrow adipocytes (BMAs) are abundant cells within the bone marrow microenvironment and are increasingly recognized for their influence on metastasis.

Purpose of the Study:

• To comprehensively review the interaction between bone marrow adipocytes (BMAs) and bone metastasis.
• To explore the mechanisms by which BMAs influence tumor cell survival, proliferation, and resistance to therapy.
• To discuss novel therapeutic strategies targeting BMAs for the prevention and treatment of bone metastasis.

Main Methods:

• Literature review synthesizing current research on BMAs and bone metastasis.
• Analysis of studies investigating BMA-derived factors (e.g., inflammatory factors, adipocytokines) and their effects on tumor cells.
• Evaluation of potential therapeutic interventions targeting BMA formation and function.

Main Results:

• BMAs provide direct energy sources and promote tumor cell proliferation and resistance to cancer therapies.
• BMAs secrete various factors that can either promote or inhibit bone metastasis.
• A fraction of circulating tumor cells (CTCs) successfully colonize bone, highlighting the critical role of the bone marrow microenvironment in determining metastatic outcome.

Conclusions:

• Bone marrow adipocytes (BMAs) are key regulators of the bone marrow microenvironment influencing cancer metastasis.
• Targeting BMAs, through genetic disruption or pharmaceutical inhibition, presents a promising therapeutic avenue.
• Further research into BMA-tumor cell interactions is crucial for developing effective strategies against bone metastasis.